Oxford Specialist Handbook: Myeloproliferative Neoplasms
Herausgeber: Mughal, Tariq I; Barbui, Tiziano
Oxford Specialist Handbook: Myeloproliferative Neoplasms
Herausgeber: Mughal, Tariq I; Barbui, Tiziano
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Our understanding of myeloproliferative neoplasms (MPN) disorders has grown considerably over the past four decades. Myeloproliferative Neoplasms offers a detailed evidence-based guide to MPNs in an easily accessible format, structure to facilitate learning specialist information presenting core information in 'bite size' chunks.
Andere Kunden interessierten sich auch für
- Oxford Textbook of Oncology274,99 €
- Himender K MakkerOxford Case Histories in Lung Cancer110,99 €
- Ian B WilkinsonOxford Handbook of Clinical Medicine, Oxford Handbook of Clinical Specialties, and Oxford Handbook for Medical School Pack123,99 €
- Oxford Textbook of Obstetrics and Gynaecology129,99 €
- Himender MakkerSleep Medicine (Oxford Case Histories)110,99 €
- Philip SeoOxford American Handbook of Rheumatology107,99 €
- Oxford Case Histories: Anaesthesia96,99 €
-
-
-
Our understanding of myeloproliferative neoplasms (MPN) disorders has grown considerably over the past four decades. Myeloproliferative Neoplasms offers a detailed evidence-based guide to MPNs in an easily accessible format, structure to facilitate learning specialist information presenting core information in 'bite size' chunks.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- Seitenzahl: 352
- Erscheinungstermin: 24. November 2020
- Englisch
- Abmessung: 178mm x 99mm x 13mm
- Gewicht: 440g
- ISBN-13: 9780198744214
- ISBN-10: 0198744218
- Artikelnr.: 59178992
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Oxford University Press
- Seitenzahl: 352
- Erscheinungstermin: 24. November 2020
- Englisch
- Abmessung: 178mm x 99mm x 13mm
- Gewicht: 440g
- ISBN-13: 9780198744214
- ISBN-10: 0198744218
- Artikelnr.: 59178992
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Following training in haematology/oncology and stem cell transplantation at Imperial College London, Professor Tariq I Mughal has held haematology/oncology leadership roles in cancer centres of excellence in London, Manchester and Denver. From an early stage in his career, he has been interested in precision haematologic cancer medicine and breast cancer. He now practices in Boston and London, and is a member of many learned societies. He is a professor of medicine and founder of Alpine Oncology Foundation dedicated to improve haematologic cancer care in economically challenged countries. He has published over 130 peer-reviewed scientific publications, 30 book chapters and authored/edited 13 books on cancers. Following training inhematology/oncology in Padova, Professor Tiziano Barbui was appointed initially as a Professor, and later as the head of the department of Haematology at the (then) Ospedale Riuniti, and now Papa Giovanni XXIII, in Bergamo (Italy). He is a past-President of the Italian Society of Haematology, and chair of the Lupus Anticoagulant Subcommittee of the International Society of Thrombosis and Haemostasis. He currently leads the Italian GIMEMA group and is the co-chair of the European-Leukemia-Net working group on Myeloproliferative Disorders. He has published over 450 peer-reviewed scientific publications and authored/edited several books and chapters.
* 1: Tariq I. Mughal and Tiziano Barbui: History of the
myeloproliferative neoplasms
* 2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael
W.Deininger: Genomic landscape of myeloproliferative neo-plasms
* 3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of
myeloproliferative neoplasms
* 4: Hans Michael Kvasnicka and Jüergen Thiele: Haematopathology of
myeloproliferative neoplasms
* 5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta,
Francesca Palandri, Simona Soverini, and Gianantonio Rosti:
Prognostic factors of chronic myeloid leukaemia
* 6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk
stratification of Myeloproliferative Neoplasms
* 7: Tariq I. Mughal: Chronic myeloid leukaemia
* 8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
* 9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
* 10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larrán:
Essential thrombocythemia
* 11: Jason Gotlib: Systemic mastocytosis
* 12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List:
Myelodysplastic syndromes/myeloproliferative neoplasms
* 13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated
myeloproliferative neoplasms
* 14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I.
Mughal: Transformation of myeloproliferative neoplasms to acute
leukaemia
* 15: Daniel Egan and Jerald P. Radich: Monitoring efforts in
myeloproliferative neoplasms
* 16: Alessandro Rambaldi and Nicholas Kröger: Stem cell
transplantation for BCR-ABL1-postive and negative myeloproliferative
neoplasms
* 17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa:
Assessment of disease burden in patients with myeloproliferative
neoplasms
* 18: Giovanni Barosi and Gianni Tognoni: Clinical trials in
bcr-abl1-negative myeloproliferative neo-plasms
myeloproliferative neoplasms
* 2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael
W.Deininger: Genomic landscape of myeloproliferative neo-plasms
* 3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of
myeloproliferative neoplasms
* 4: Hans Michael Kvasnicka and Jüergen Thiele: Haematopathology of
myeloproliferative neoplasms
* 5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta,
Francesca Palandri, Simona Soverini, and Gianantonio Rosti:
Prognostic factors of chronic myeloid leukaemia
* 6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk
stratification of Myeloproliferative Neoplasms
* 7: Tariq I. Mughal: Chronic myeloid leukaemia
* 8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
* 9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
* 10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larrán:
Essential thrombocythemia
* 11: Jason Gotlib: Systemic mastocytosis
* 12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List:
Myelodysplastic syndromes/myeloproliferative neoplasms
* 13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated
myeloproliferative neoplasms
* 14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I.
Mughal: Transformation of myeloproliferative neoplasms to acute
leukaemia
* 15: Daniel Egan and Jerald P. Radich: Monitoring efforts in
myeloproliferative neoplasms
* 16: Alessandro Rambaldi and Nicholas Kröger: Stem cell
transplantation for BCR-ABL1-postive and negative myeloproliferative
neoplasms
* 17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa:
Assessment of disease burden in patients with myeloproliferative
neoplasms
* 18: Giovanni Barosi and Gianni Tognoni: Clinical trials in
bcr-abl1-negative myeloproliferative neo-plasms
* 1: Tariq I. Mughal and Tiziano Barbui: History of the
myeloproliferative neoplasms
* 2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael
W.Deininger: Genomic landscape of myeloproliferative neo-plasms
* 3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of
myeloproliferative neoplasms
* 4: Hans Michael Kvasnicka and Jüergen Thiele: Haematopathology of
myeloproliferative neoplasms
* 5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta,
Francesca Palandri, Simona Soverini, and Gianantonio Rosti:
Prognostic factors of chronic myeloid leukaemia
* 6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk
stratification of Myeloproliferative Neoplasms
* 7: Tariq I. Mughal: Chronic myeloid leukaemia
* 8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
* 9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
* 10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larrán:
Essential thrombocythemia
* 11: Jason Gotlib: Systemic mastocytosis
* 12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List:
Myelodysplastic syndromes/myeloproliferative neoplasms
* 13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated
myeloproliferative neoplasms
* 14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I.
Mughal: Transformation of myeloproliferative neoplasms to acute
leukaemia
* 15: Daniel Egan and Jerald P. Radich: Monitoring efforts in
myeloproliferative neoplasms
* 16: Alessandro Rambaldi and Nicholas Kröger: Stem cell
transplantation for BCR-ABL1-postive and negative myeloproliferative
neoplasms
* 17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa:
Assessment of disease burden in patients with myeloproliferative
neoplasms
* 18: Giovanni Barosi and Gianni Tognoni: Clinical trials in
bcr-abl1-negative myeloproliferative neo-plasms
myeloproliferative neoplasms
* 2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael
W.Deininger: Genomic landscape of myeloproliferative neo-plasms
* 3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of
myeloproliferative neoplasms
* 4: Hans Michael Kvasnicka and Jüergen Thiele: Haematopathology of
myeloproliferative neoplasms
* 5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta,
Francesca Palandri, Simona Soverini, and Gianantonio Rosti:
Prognostic factors of chronic myeloid leukaemia
* 6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk
stratification of Myeloproliferative Neoplasms
* 7: Tariq I. Mughal: Chronic myeloid leukaemia
* 8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
* 9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
* 10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larrán:
Essential thrombocythemia
* 11: Jason Gotlib: Systemic mastocytosis
* 12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List:
Myelodysplastic syndromes/myeloproliferative neoplasms
* 13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated
myeloproliferative neoplasms
* 14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I.
Mughal: Transformation of myeloproliferative neoplasms to acute
leukaemia
* 15: Daniel Egan and Jerald P. Radich: Monitoring efforts in
myeloproliferative neoplasms
* 16: Alessandro Rambaldi and Nicholas Kröger: Stem cell
transplantation for BCR-ABL1-postive and negative myeloproliferative
neoplasms
* 17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa:
Assessment of disease burden in patients with myeloproliferative
neoplasms
* 18: Giovanni Barosi and Gianni Tognoni: Clinical trials in
bcr-abl1-negative myeloproliferative neo-plasms